SEOUL, South Korea, Jan. 10, 2025 /PRNewswire/ -- SN BioScience today announced that its lead asset SNB-101 has received Investigational New Drug (IND) clearance from the U.S. Food and Drug ...
This release, which is published quarterly, includes commentary on market developments and monetary policy operations, along with reports on a range of domestic and international economic issues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback